Chronic Pain Therapy Solutions for Joints Companies and Financial Performance Evaluation

Top Companies in the Chronic Pain Therapy Solutions for Joints Market with Latest Offerings

Abbott Laboratories

Description: They usually explore various advanced implantable neuromodulation devices, as well as topical and oral pharmaceutical products.

Medtronic plc

Description: It unveiled variations in Sacroiliac (SI) Joint Fusion, Kyphoplasty, and Radiofrequency (RF) Ablation, etc.

Boston Scientific Corporation

Description: This mainly provides specialized interventional therapies to treat chronic joint pain.

Johnson & Johnson

Description: It facilitates solutions through its DePuy Synthes MedTech division and novel medicine portfolio.

Zimmer Biomet Holdings, Inc.

Description: This specialises in non-surgical to robotic-assisted surgical solutions, including restorative therapies, biologics, and surgical reconstruction.

Stryker Corporation

Description: A firm focuses on radiofrequency ablation, vertebral augmentation, and joint reconstruction technologies.

Sanofi S.A.

Description: It plays a major role in developing viscosupplementation for knee osteoarthritis (OA).

Anika Therapeutics, Inc.

Description: This company offers solutions for chronic joint pain through its proprietary hyaluronic acid (HA) technology.

Bioventus Inc.

Description: It facilitates non-surgical hyaluronic acid (HA) injections for osteoarthritis (OA) & peripheral nerve stimulation (PNS) for nerve-related chronic pain.

Pacira BioSciences, Inc

Description: This introduced several non-opioid, targeted therapies to manage chronic joint pain, like ZILRETTA, iovera, etc.

Chronic Pain Therapy Solutions for Joints Market- Value Chain Analysis

R&D

• Research activities mainly emphasise a "solution-agnostic" model, executing biologics, peptides, small molecules, & regenerative medicine to treat osteoarthritis and neuropathic pain.
• Key Players: Grünenthal, Sanofi, Johnson & Johnson, etc.

Clinical Trials & Regulatory Approvals

• This clinical trials primarily covers preclinical testing, four phases of human trials, and robust oversight by regulatory agencies, especially the FDA.
• Key Players: Waldemar Link GmbH & Co. KG, University of Jordan, Istituto Ortopedico Rizzoli, etc.

Patient Support & Services

• Firms are implementing clinical treatments and physical rehabilitation to education and psychological support, focused on assisting patients in managing their condition and lowering reliance on medication.
• Key Players: SBF Healthcare, HopeQure, ASA Healthcare, etc.

Market Growth

The global chronic pain therapy solutions for joints market size was estimated at USD 5.15 billion in 2025 and is predicted to increase from USD 5.4 billion in 2026 to approximately USD 8.28 billion by 2035, expanding at a CAGR of 4.86% from 2026 to 2035.

Become a valued research partner with us, please feel free to contact us at sales@towardshealthcare.com